HemoShear Attends Piper Sandler Conference
CHARLOTTESVILLE, Va., May 18, 2023 /PRNewswire/ — HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, participated in the Piper Sandler Spring Biopharma Symposium being held in Boston, MA, Wednesday, May 17 through Thursday, May 18, 2023. The HemoShear management team, led by Brian Wamhoff, Interim CEO, briefed institutional investors on the latest company … Read more